zolbetuximab
EMA accepts Astellas’ MAA for Zolbetuximab
July 14, 2023Medical Communications Astellas, Cancer, EMA, Oncology, zolbetuximab
Astellas Pharma has announced that the European Medicines Agency (EMA) has accepted the company’s marketing authorisation application (MAA) for regulatory …
Latest content
MedPharm appoints Jason Mieding as chief operating officer
November 8, 2026
The evidence bar impacting UK medical cannabis access
November 6, 2026
